Gemzar 1000 mg Norge - norsk - Statens legemiddelverk

gemzar 1000 mg

eli lilly norge as - gemcitabinhydroklorid - pulver til infusjonsvæske, oppløsning - 1000 mg

Fentanyl ratiopharm 75 mikrog/ time Norge - norsk - Statens legemiddelverk

fentanyl ratiopharm 75 mikrog/ time

ratiopharm gmbh - fentanyl - depotplaster - 75 mikrog/ time

Fentanyl ratiopharm 12 mikrog/ time Norge - norsk - Statens legemiddelverk

fentanyl ratiopharm 12 mikrog/ time

ratiopharm gmbh - fentanyl - depotplaster - 12 mikrog/ time

Fentanyl ratiopharm 25 mikrog/ time Norge - norsk - Statens legemiddelverk

fentanyl ratiopharm 25 mikrog/ time

ratiopharm gmbh - fentanyl - depotplaster - 25 mikrog/ time

Fentanyl ratiopharm 50 mikrog/ time Norge - norsk - Statens legemiddelverk

fentanyl ratiopharm 50 mikrog/ time

ratiopharm gmbh - fentanyl - depotplaster - 50 mikrog/ time

Fentanyl ratiopharm 100 mikrog/ time Norge - norsk - Statens legemiddelverk

fentanyl ratiopharm 100 mikrog/ time

ratiopharm gmbh - fentanyl - depotplaster - 100 mikrog/ time

Pemetrexed Baxter Den europeiske union - norsk - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiske midler - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Jevtana Den europeiske union - norsk - EMA (European Medicines Agency)

jevtana

sanofi winthrop industrie - cabazitaxel - prostata neoplasmer - antineoplastiske midler - jevtana i kombinasjon med prednison eller prednisolon er indisert for behandling av pasienter med hormon-ildfast metastatisk prostatakreft som tidligere er behandlet med en docetaxelholdig diett.

Nordimet Den europeiske union - norsk - EMA (European Medicines Agency)

nordimet

nordic group b.v. - methotrexate - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastiske midler - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

Tecfidera Den europeiske union - norsk - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dimetylfumarat - multippel sklerose - immunsuppressive - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).